Close Menu

NEW YORK – Life sciences firm LGC announced Monday that it is acquiring Technopath Clinical Diagnostics, a manufacturer of quality control solutions for clinical laboratories, for an undisclosed amount.

Technopath's chemistry and immunoassay controls will be brought into LGC's clinical diagnostics business unit. 

Other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.